Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction ; volume:150 ; number:1 ; day:9 ; month:1 ; year:2024 ; pages:1-9 ; date:1.2024
Journal of cancer research and clinical oncology ; 150, Heft 1 (9.1.2024), 1-9, 1.2024
- Urheber
-
Xu, Juqing
Chen, Haiming
Fan, Weifei
Qiu, Mantang
Feng, Jifeng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-023-05521-4
- URN
-
urn:nbn:de:101:1-2404170747079.952456755913
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xu, Juqing
- Chen, Haiming
- Fan, Weifei
- Qiu, Mantang
- Feng, Jifeng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plasma cell-free DNA: a potential biomarker for early prediction of severe dengue
Plasma Cell-Free DNA Is a Potential Biomarker for Diagnosis of Calcific Aortic Valve Disease
Dexosomes as a cell-free vaccine for cancer immunotherapy
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
Quantitative analysis of cell-free plasma DNA as a prognostic biomarker in acute ischemic stroke patients
The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study
Cell-free microRNA-21: biomarker for intracranial aneurysm rupture
TCR diversity – a universal cancer immunotherapy biomarker?
Plasma cell-free DNA in patients needing mechanical ventilation
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
Biomarker potential of the GRP78 cell-free RNA in endometrial cancer
Detection of Apparent Cell-free M. tuberculosis DNA from Plasma
Plasma cell-free DNA: a potential biomarker for early prediction of severe dengue
Plasma Cell-Free DNA Is a Potential Biomarker for Diagnosis of Calcific Aortic Valve Disease
Dexosomes as a cell-free vaccine for cancer immunotherapy
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
Quantitative analysis of cell-free plasma DNA as a prognostic biomarker in acute ischemic stroke patients
The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study
Cell-free microRNA-21: biomarker for intracranial aneurysm rupture
TCR diversity – a universal cancer immunotherapy biomarker?
Plasma cell-free DNA in patients needing mechanical ventilation
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
Biomarker potential of the GRP78 cell-free RNA in endometrial cancer
Detection of Apparent Cell-free M. tuberculosis DNA from Plasma
Plasma cell-free DNA: a potential biomarker for early prediction of severe dengue
Plasma Cell-Free DNA Is a Potential Biomarker for Diagnosis of Calcific Aortic Valve Disease
Dexosomes as a cell-free vaccine for cancer immunotherapy
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
Quantitative analysis of cell-free plasma DNA as a prognostic biomarker in acute ischemic stroke patients
The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study
Cell-free microRNA-21: biomarker for intracranial aneurysm rupture
TCR diversity – a universal cancer immunotherapy biomarker?
Plasma cell-free DNA in patients needing mechanical ventilation
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
Biomarker potential of the GRP78 cell-free RNA in endometrial cancer